The cancer cells require constant signals for their survival, growth, and dissemination to other body parts. In case of prostate cancer, male hormones, which are known as androgens, including the most common one, testosterone, initiate signaling pathways that lead to the growth of the cancer cells. However, there are instances where even though the level of the male hormones is lowered using the method of hormone therapy, prostate cancer still progresses. The state is referred to as metastatic castration-resistant prostate cancer. Bdenza 40 mg Capsule is an androgen receptor antagonist, used in the treatment of a specific kind of prostate cancer.
How Does Bdenza 40 mg Capsule Block Androgen Receptor Signalling?
Androgen receptors are a class of protein that accepts messages from male hormones. The process by which testosterone binds with the androgen receptors causes the activation of genes responsible to develop prostate cancer cells. Budenza 40 mg Capsule inhibits this process in several ways:
Inhibits androgens from being activated by the receptors.
Blocks androgen receptors from being transported into the nucleus of the cells.
Hinders the receptor from binding with DNA.
Inhibits the activation of genes responsible for cell growth.
Why Does Prostate Cancer Progress Despite Low Testosterone Levels?
Cancerous cells might grow despite lowering the levels of testosterone. This is so because the cells acquire alterations that enable androgen receptor signaling to persist. These may be caused by the enhanced sensitivity of the receptor and other molecular modifications. The use of this targeted hormonal therapy resolves this issue by inhibiting the androgen receptors instead of just reducing the levels of testosterone.
How Is The Capsule Different from Conventional Hormone Therapy?
Unlike hormone therapy, which focuses mainly on decreasing the production of testosterone, this medicine acts by inhibiting the androgen receptor. This distinction enables Bdenza 40 mg Capsule to inhibit the hormone signal even where the concentration of testosterone is very low. In mCRPC, it is usually administered with ongoing androgen deprivation therapy.
What Are the Benefits of The Medicine?
The benefits associated with treatment through the Capsule are:
1. Blocking of hormone signals: Inhibits androgen receptors to activate growth mechanisms.
2. Limiting cancer cell proliferation: Blocks genetic codes responsible for the proliferation of cancer cells.
3. Helping in managing advanced cancer: Offers treatment for selected patients with metastatic prostate cancer.
4. Delaying the development of cancer: Delays the progression of cancer in suitable patient populations.
What Changes in the Body May Be Experienced Caused By The Medicine?
There are some possible side effects in the patients undergoing the therapy which include:
Fatigue
Hot flushes
High blood pressure
Headaches
Loss of appetite
Joint/muscle pain
Falls and bone fractures
There is also the possibility of developing a few yet serious complications like seizures. Medical practitioners are supposed to keep an eye on the patient for any abnormal neurological problems that might arise during treatment.
How To Administered The Medications During The Treatment?
Generally, the standard adult dose for the capsule to be taken orally every day, which may necessitate the taking of four 40 mg capsules. The oncologist may change the dose depending on treatment efficacy and the patient’s tolerance to the drug. The patients must take the medicine as per the doctor's instructions and take the capsule whole along with water, and maintain consistent dosing.
Conclusion
This Bdenza 40 mg capsule benefits and uses in prostate cancer manages through the inhibition of the function of androgen receptors. Enzalutamide is the ingredient present in this medicine which blocks the hormones from communicating and inhibits the genes involved in the growth of prostate cancer cells. This is a beneficial medication for treating eligible patients of prostate cancer that have advanced due to low levels of testosterone.
FAQs
1. Is the capsule a chemotherapy drug?
No. It is a hormone-based anti-cancer drug referred to as an androgen receptor inhibitor. It operates differently from typical chemotherapy medications.
2. Does the medicine interact well with other drugs for treating prostate cancer?
Yes. It interacts well with other drugs such as the androgen deprivation therapy drug or other drugs, based on the treatment plan.
